10 2 Full Volume (PDF) - Journal of Cell and Molecular Biology ...

Barlow M and Hall BG. Predicting evolutionary
potential: in vitro evolution accurately
reproduces natural evolution of the TEM -
lactamase. Genetics. 160: 823–832, 2002.
German B and Martinez-Beltran J. Cloning,
Nucleotide Sequencing, and Analysis of the
Gene Encoding an AmpC b-Lactamase in
Acinetobacter baumannii. Antimicrobial Agents
and Chemotherapy. 44(2): 428–432, 2000.
Ford PJ and Avison MB. Evolutionary mapping of
the SHV b-lactamase and evidence for two
separate IS26-dependent blaSHV mobilization
events from the Klebsiella pneumoniae
chromosome. Journal of Antimicrobial
Chemotherapy. 54: 69 – 75, 2004.
Gniadkowski M, Schneider I, Jungwirth R, et al.
Ceftazidime Resistant Enterobacteriaceae
isolates from three Polish Hospitals:
Identification of three novel TEM- and SHV-5
type Extended Spectrum Beta Lactamases.
Antimicrobial Agents and Chemotherapy. 42(3):
514-520, 1998.
Hall BG and Barlow M. Evolution of the serine
beta-lactamases: past, present and future. Drug
Resistance Update.7: 111–123, 2004.
Kim J, Lim Y, Jeong Y and Seol S. Occurrence of
CTX-M-3, CTX-M-15, CTX-M-14, and CTX-
M-9 Extended-Spectrum Beta Lactamases in
Enterobacteriaceae Clinical Isolates in Korea.
Antimicrob Agents Chemother. 49(4): 1572–
1575, 2005.
Mazel D, Dychinco B, Webb VA, and J. Davies.
Antibiotic resistance in the ECOR collection:
integrons and identification of a novel aad gene.
Antimicrob Agents Chemother. 44:1568–1574.
2000.
Mshana SE, Imirzalioglu C, Hossain H, et al.
Conjugative IncFI plasmids carrying CTX-M-
15 among Escherichia coli ESBL producing
isolates at a University hospital in Germany.
BioMedCentral (BMC) Infectious Diseases. 9:
97, 2009.
Mendonça N, Leitão J, Manageiro V, et al. Spread
of extended spectrum b-lactamase CTX-M-
K. pneumonia isolates with ESBL activity 51
producing Escherichia coli clinical
isolates in community and nosocomial
environments in Portugal. Antimicrob
Agents Chemother. 51:1946-1955, 2007.
Nikaido H. Outer membrane barrier as a
mechanism of antimicrobial resistance.
Antimicrob Agents Chemother. 33:1831-
1836, 1989.
Jonathan N. Screening for Extended-
Spectrum Beta-Lactamase-Producing
Pathogenic Enterobacteria in District
General Hospitals. J Clin Microbiol. 43:
1488–1490, 2005.
Poirel L, Naas T, Guibert M, et al.
Molecular and biochemical
characterization of VEB-1, a novel class
A extended-spectrum b-lactamase
encoded by an Escherichia coli integron
gene. Antimicrob Agents Chemother.
43:573–581, 1999.
Poirel L, Le Thomas I, Naas T, et al.
Biochemical sequence analyses of GES-
1, a novel class A extended-spectrum blactamase,
and the class 1 integron In52
from Klebsiella pneumoniae. Antimicrob
Agents Chemother. 44: 622–632, 2000.
Rotimi V, Jamal W, Pal T, et al. Emergence
of CTX-M-15 type extended-spectrum blactamase-producing
Salmonella spp. in
Kuwait and the United Arab Emirates. J
Med Microbiol. 57: 881–886, 2008.
Ben-Hamouda T, Foulon T, Ben cheikh-
Masmoudi A, et al. Molecular
epidemiology of an outbreak of multi
resistant Klebsiella pneumoniae in a
Tunisian neonatal ward. Journal of
Medical Microbiology. 52(5): 427-433,
2003.
Wu TL, Siu LK, Su LH, et al. Outer
membrane protein change combined
with co-existing TEM-1 and SHV-1 beta
lactamases lead to false identification of
ESBL producing Klebsiella pneumoniae.
J Antimicrob Chemother. 47:755-761,
2001.